-
Published 8/1/2025
Tzelios CA, Malatesta S, Carney T, White LF, Weber SE, Thomson S, Theron D, Myers B, Parry CDH, Warren RM, Horsburgh CR, Farhat MR, Jacobson KR. Patient Determinants and Effects on Adherence of Adverse Drug Reactions to Tuberculosis Treatment: A Prospective Cohort Analysis. Clin Infect Dis. 2025 Aug 01; 81(1):167-175. PMID: 39973802.
-
Published 7/1/2025
Phillips PPJ, Peloquin CA, Sterling TR, Kaur P, Diacon AH, Gotuzzo E, Benator D, Warren RM, Sikes D, Lecca L, Gandhi NR, Streicher EM, Dianis N, Eisenach K, Mitnick CD, Horsburgh CR. Efficacy and Safety of Higher Doses of Levofloxacin for Multidrug-resistant Tuberculosis: A Randomized, Placebo-controlled Phase II Clinical Trial. Am J Respir Crit Care Med. 2025 Jul; 211(7):1277-1287. PMID: 40080768.
-
Published 6/1/2025
Menzies NA, Marks SM, Hsieh YL, Swartwood NA, Beeler Asay GR, Skarbinski J, Horsburgh CR, Cohen T. Contribution of Posttuberculosis Sequelae to Life-Years Lost from Tuberculosis Disease in the United States, 2015-2019. Am J Respir Crit Care Med. 2025 Jun; 211(6):1059-1068. PMID: 39928299.
-
Published 5/25/2025
Koura KG, Soe AN, Dlodlo RA, Lin Y, Sinha P, Badoum G, Dogo MF, Horsburgh CR, Harries AD. Impact of US Government funding cessation on TB care and prevention: a multicountry survey in Africa. Int J Tuberc Lung Dis. 2025 May 25; 29(5):239-241. PMID: 40281676.
-
Published 5/20/2025
Subramanian S, Chinnakali P, Prakashbabu S, Visvanadane GN, Rajaram M, Viswanathan V, Sarkar S, Horsburgh CR. Prevalence, Conversion and Reversion of Tuberculosis Infection Among Healthcare Workers of Tertiary Care Centres in Puducherry, India: A Prospective Cohort Study. Trop Med Infect Dis. 2025 May 20; 10(5). PMID: 40423370.